Abstract:Recombinant immunotoxins consisting of small antibody fragments fused to cytotoxic moieties are being evaluated for use in prospective antibody-targeted cancer therapies. A receptor tyrosine kinase known as c-Met is overexpressed in a vast range of human malignancies, making it an ideal target for antibody-mediated delivery of numerous cytotoxic agents. A single Fab molecule capable of binding to human c-Met with high affinity and specificity was previously identified using antibody phage-display technology. In order to develop a molecule to increase both the cytotoxicity and anti-tumor activity of the anti-c-Met molecule, a recombinant immunotoxin anti-c-Met/PE38KDEL was constructed and expressed by fusing the human anti-c-Met single-chain variable fragment (ScFv) with a modified Pseudomonas exotoxin A (PE38KDEL). Purified anti-c-Met/PE38KDEL was demonstrated to specifically bind to cells of c-Met-positive human hepatoma cell lines, causing a proliferation defect by inducing caspase-3/8-mediated apoptosis, as observed by in vitro assays. Furthermore, anti-c-Met/PE38KDEL administration was shown to inhibit the growth of hepatocellular carcinoma xenografts in vivo through suppression of Ki-67 expression and enhancement of tumor cell apoptosis rates. Cumulatively, the current findings demonstrate the successful construction of a recombinant immunotoxin capable of accurately targeting c-Met-positive human hepatoma cell lines both in vitro and in vivo, providing a novel compound with potential for applications as an alternative therapy for c-Met-positive cancer management.

Expression,purification and Preliminary Identification of a Novel Immunotoxin Against Hepatocarcinoma

Enhanced Binding to and Killing of Hepatocellular Carcinoma Cells in Vitro by Melittin when Linked with a Novel Targeting Peptide Screened from Phage Display

Identification and Localization of Hepatocarcinoma-Specific Adhesion Peptide

Construction and characterization of an anti-asialoglycoprotein receptor single-chain variable-fragment-targeted melittin.

Construction, expression, and characterization of an anti-tumor immunotoxin containing the human anti-c-Met single-chain antibody and PE38KDEL

Construction and Expression of a Humanoral Recombinant Immunotoxin Against Hepatocellular Carcinoma and Its Killing Effect on HCC Cell Line

Targeting of Hepatoma Cell and Suppression of Tumor Growth by A Novel 12mer Peptide Fused to Superantigen Tsst-1

Expression and functional detection of recombinant immunotoxins anti-B7-H4-scFv/PE38KDEL

THE RECOMBINANT ANTI-MAGE-A1 IMMUNOTOXIN INHIBITED THE GROWTH OF HEPTACELLULAR CARCINOMA CELL BEL7402

An Upa Cleavable Conjugate Of A Recombinant Alpha V Beta 3 Targeting Toxin And Its Bioactivity

Preparation and Functional Characterization of Human Vascular Endothelial Growth Factor-Melittin Fusion Protein with Analysis of the Antitumor Activity in Vitro and in Vivo.

Selection and Preliminary Identification of Hepatocarcinoma-Binding and Internalizing Peptide

A Liver-Tumor Adhesion Peptide from Random Phage Display Library

In vitro targeted therapy by hepatocarcinoma-specific peptide A54

Construction of Membrane-lytic Immunotoxin by Melittin and Epidermal Growth Factor

Expression and Functional Characterization of a Recombinant Targeted Toxin with an Upa Cleavable Linker in Pichia Pastoris.

[Expression, Purification and Activity Analysis of Human Single-Chain Antibody Against Hepatocellular Cancer].

Selection and Characterization of Human Anti-MAGE-A1 Scfv and Immunotoxin

Anti-hepatocarcinoma activity of TT-1, an analog of melittin, combined with interferon-α via promoting the interaction of NKG2D and MICA

An uPA cleavable conjugate of a recombinant αvβ3 targeting toxin and its bioactivity

Design, Expression, Purification and Characterization of the Recombinant Immunotoxin 4D5 Scfv-Trail